INVESTIGATIONAL · NOT AVAILABLE FOR SALE

IothaFoam™

Iodinated polyurethane foam wound dressing

A moist, iodine-releasing foam dressing designed to clear biofilm while staying compatible with healing tissue. Already manufactured in full size by a U.S. medical foam converter.

IothaFoam sample pouch beside a piece of the foam dressing
At a glance

Used like any foam dressing.

No new workflow for nurses and wound care teams: open the pouch, cut to size, apply.

Construction
Medical polyurethane open-cell foam, laminated to a breathable polyurethane film
Active
Iodine held in the foam's open cells, released slowly into the wound
Supplied
Moist, in a sealed pouch
Full size
25 × 25 cm; cut to size with scissors
Sample size
4 in × 4 in × 0.2 in
Wear time
Designed for days between changes, not hours
On removal
Non-adherent: lifts without tearing new tissue
Regulatory
Class II 510(k) pathway · FDA Pre-Submission Q253783 complete
IP
Patent pending, US 2025/0064645 A1
How it's made

Made in Ohio. Seven steps, one of them chemistry.

Everything except the iodine bath is standard medical-foam converting — so scale means more batches and a second shift, not new capital equipment.

  1. 01FoamOpen-cell medical polyurethane
  2. 02Pre-wetPrepared for uptake
  3. 03IodinateThe only chemistry step
  4. 04DryControlled, to spec
  5. 05LaminateBreathable film
  6. 06Cut25 × 25 cm
  7. 07PouchSealed moist, labelled
U.S.-sourced polyurethane foam, breathable film and USP iodine — all commercial, all domestic.
Regulatory path

510(k). FDA has already reviewed the test plan.

Class II wound dressing · Pre-Submission Q253783 complete · predicate and test plan agreed. No clinical trial required for clearance.

2026 · DONE
Pre-Sub done
Predicate and test plan agreed with FDA
NOW
Testing
The verification program FDA asked for
Q2 2027
510(k) filed
On the agreed data set
H2 2027
FDA decision
Expected
2028
Launch
Federal and home-health channels first
Dates after filing are expectations; FDA review time is not under the company's control.
Platform

The dressing is the first product. The chemistry is the company.

LEAD PRODUCT
IothaFoam™ dressing

Manufactured; heading into the 510(k) test program.

NEXT
More formats

Additional sizes and shapes on the same foam after first clearance.

IN DEVELOPMENT
Iodinated catheter

A sustained-iodine Foley catheter on the same science; patent in progress. About 560,000 catheter-associated urinary tract infections occur each year in the U.S.

DESIGN INTENT
Graft-compatible

Designed for spray-on skin and cell-therapy workflows, where silver sulfadiazine is already excluded.

CAUTI: CDC / AHRQ. Cell-therapy compatibility is a design intent, not a tested claim.

Wound care clinician or research partner? We'd like to hear from you.

Contact us
IOTHANE MEDICAL
1515 El Camino Real, Suite D, Palo Alto, CA 94306
CAUTION: IothaFoam™ is an investigational device. It has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.
IothaFoam™ is a trademark of IOTHANE Medical, Inc. Patent pending (US 2025/0064645 A1). Content on this site is for general information only and is not medical advice. Images are illustrative.
© 2026 IOTHANE Medical, Inc. All rights reserved.Privacy PolicyTerms of UseReferences